Institute for Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany.
J Am Coll Cardiol. 2011 Nov 29;58(23):2415-23. doi: 10.1016/j.jacc.2011.08.033.
Here we assess the intrinsic functions of the chemokine receptor CXCR4 in remodeling after myocardial infarction (MI) using Cxcr4 heterozygous (Cxcr4(+/-)) mice.
Myocardial necrosis triggers complex remodeling and inflammatory changes. The chemokine CXCL12 has been implicated in protection and therapeutic regeneration after MI through recruiting angiogenic outgrowth cells, improving neovascularization and cardiac function, but the endogenous role of its receptor CXCR4 is unknown.
MI was induced by ligation of the left descending artery. Langendoff perfusion, echocardiography, quantitative immunohistochemistry, flow cytometry, angiogenesis assays, and cardiomyocyte analysis were performed.
After 4 weeks, infarct size was reduced in Cxcr4(+/-) mice compared with wild-type mice and in respective bone marrow chimeras compared with controls. This was associated with altered inflammatory cell recruitment, decreased neutrophil content, delayed monocyte infiltration, and a predominance of Gr1(low) over classic Gr1(high) monocytes. Basal coronary flow and its recovery after MI were impaired in Cxcr4(+/-)mice, paralleled by reduced angiogenesis, myocardial vessel density, and endothelial cell count. Notably, no differences in cardiac function were seen in Cxcr4(+/-)mice compared with wild-type mice. Despite defective angiogenesis, Cxcr4(+/-) mouse hearts showed no difference in CXCL12, vascular endothelial growth factor or apoptosis-related gene expression. Electron microscopy revealed lipofuscin-like lipid accumulation in Cxcr4(+/-) mouse hearts and analysis of lipid extracts detected high levels of phosphatidylserine, which protect cardiomyocytes from hypoxic stress in vitro.
CXCR4 plays a crucial role in endogenous remodeling processes after MI, contributing to inflammatory/progenitor cell recruitment and neovascularization, whereas its deficiency limits infarct size and causes adaptation to hypoxic stress. This should be carefully scrutinized when devising therapeutic strategies involving the CXCL12/CXCR4 axis.
本研究旨在利用趋化因子受体 CXCR4 杂合子(Cxcr4(+/-))小鼠评估其在心梗后重塑过程中的内在功能。
心肌坏死引发复杂的重塑和炎症变化。趋化因子 CXCL12 通过募集血管生成生长细胞、改善新生血管化和心功能,在心梗后保护和治疗再生中发挥作用,但尚不清楚其受体 CXCR4 的内源性作用。
通过结扎左冠状动脉降支诱导心梗。进行 Langendoff 灌注、超声心动图、定量免疫组织化学、流式细胞术、血管生成测定和心肌细胞分析。
4 周后,与野生型小鼠相比,Cxcr4(+/-)小鼠的梗死面积减小,与对照组相比,各自的骨髓嵌合体中的梗死面积也减小。这与炎症细胞募集改变、中性粒细胞含量减少、单核细胞浸润延迟以及 Gr1(low)单核细胞为主有关。与野生型小鼠相比,Cxcr4(+/-)小鼠的基础冠状动脉血流及其心梗后的恢复受损,同时伴有血管生成、心肌血管密度和内皮细胞计数减少。值得注意的是,与野生型小鼠相比,Cxcr4(+/-)小鼠的心功能无差异。尽管血管生成受损,但 Cxcr4(+/-)小鼠的心脏在 CXCL12、血管内皮生长因子或与凋亡相关的基因表达方面没有差异。电子显微镜显示 Cxcr4(+/-)小鼠心脏中有类脂褐素样脂质堆积,脂质提取物分析检测到高水平的磷脂酰丝氨酸,其在体外可保护心肌细胞免受缺氧应激。
CXCR4 在心梗后的内源性重塑过程中起着至关重要的作用,有助于募集炎症/祖细胞和新生血管化,而其缺失则限制了梗死面积并导致对缺氧应激的适应。在设计涉及 CXCL12/CXCR4 轴的治疗策略时,应仔细研究这一点。